Literature DB >> 8034294

Characterization of mutations on the rare duplicated C4/CYP21 haplotype in steroid 21-hydroxylase deficiency.

A Wedell1, B Stengler, H Luthman.   

Abstract

We have defined the mutations causing congenital adrenal hyperplasia in three Swedish patients carrying a rare haplotype containing two mutated steroid 21-hydroxylase genes (CYP21) in addition to one pseudogene (CYP21P). The presence of such haplotypes complicates genetic diagnosis and screening of mutations in 21-hydroxylase deficiency, and we show how these genotypes can be resolved by amplification and analysis of each gene separately. In all cases, the rare haplotype carried the same combination of disease-causing mutations; one of the genes had the splice mutation at base 659 in intron 2, and the other had the nonsense mutation at base 1999 in exon 8 (CAG to TAG). We have thus characterized the most common haplotype containing duplicated CYP21 genes. The frequency of this haplotype is low, and if additional such haplotypes are present, they are rare in this population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034294     DOI: 10.1007/bf02272841

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support.

Authors:  T Hultman; S Ståhl; E Hornes; M Uhlén
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

2.  Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency.

Authors:  E Mornet; P Crété; F Kuttenn; M C Raux-Demay; J Boué; P C White; A Boué
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

3.  Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products.

Authors:  Y Higashi; A Tanae; H Inoue; T Hiromasa; Y Fujii-Kuriyama
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Nonsense mutation causing steroid 21-hydroxylase deficiency.

Authors:  H Globerman; M Amor; K L Parker; M I New; P C White
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

5.  Haplotypes of the steroid 21-hydroxylase gene region encoding mild steroid 21-hydroxylase deficiency.

Authors:  B Haglund-Stengler; E Martin Ritzén; J Gustafsson; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions.

Authors:  A Helmberg; M T Tusie-Luna; M Tabarelli; R Kofler; P C White
Journal:  Mol Endocrinol       Date:  1992-08

7.  Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency.

Authors:  Y Higashi; T Hiromasa; A Tanae; T Miki; J Nakura; T Kondo; T Ohura; E Ogawa; K Nakayama; Y Fujii-Kuriyama
Journal:  J Biochem       Date:  1991-04       Impact factor: 3.387

8.  A missense mutation at Ile172----Asn or Arg356----Trp causes steroid 21-hydroxylase deficiency.

Authors:  S H Chiou; M C Hu; B C Chung
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

9.  Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations.

Authors:  A Wedell; E M Ritzén; B Haglund-Stengler; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia.

Authors:  N R Rodrigues; I Dunham; C Y Yu; M C Carroll; R R Porter; R D Campbell
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

View more
  15 in total

1.  Mutation analysis of the CYP21A2 gene in the Iranian population.

Authors:  Bahareh Rabbani; Nejat Mahdieh; Mohammad Tahgi Haghi Ashtiani; Bagher Larijani; Mohammad Taghi Akbari; Maria New; Alan Parsa; Jan P Schouten; Ali Rabbani
Journal:  Genet Test Mol Biomarkers       Date:  2011-10-21

2.  Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Gabriela P Finkielstain; Wuyan Chen; Sneha P Mehta; Frank K Fujimura; Reem M Hanna; Carol Van Ryzin; Nazli B McDonnell; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2010-10-06       Impact factor: 5.958

3.  A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics.

Authors:  Márton Doleschall; Andrea Luczay; Klára Koncz; Kinga Hadzsiev; Éva Erhardt; Ágnes Szilágyi; Zoltán Doleschall; Krisztina Németh; Dóra Török; Zoltán Prohászka; Balázs Gereben; György Fekete; Edit Gláz; Péter Igaz; Márta Korbonits; Miklós Tóth; Károly Rácz; Attila Patócs
Journal:  Eur J Hum Genet       Date:  2017-04-12       Impact factor: 4.246

4.  Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency).

Authors:  Dianne Keen-Kim; Joy B Redman; Reno U Alanes; Michele M Eachus; Robert C Wilson; Maria I New; Jon M Nakamoto; Raymond G Fenwick
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

5.  Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.

Authors:  Maria I New; Moolamannil Abraham; Brian Gonzalez; Miroslav Dumic; Maryam Razzaghy-Azar; David Chitayat; Li Sun; Mone Zaidi; Robert C Wilson; Tony Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

6.  A rare CYP21A2 haplotype clarifies the phenotype-genotype discrepancy in an Italian patient with Non Classical Congenital Adrenal Hyperplasia (NC-CAH).

Authors:  Paola Concolino
Journal:  Mol Biol Rep       Date:  2020-03-17       Impact factor: 2.316

Review 7.  Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.

Authors:  Paola Concolino; Alessandra Costella
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.074

8.  Genotype in the diagnosis of 21-hydroxylase deficiency: who should undergo CYP21A2 analysis?

Authors:  P Cavarzere; M Vincenzi; F Teofoli; R Gaudino; S Lauriola; E Maines; M Camilot; F Antoniazzi
Journal:  J Endocrinol Invest       Date:  2013-09-27       Impact factor: 4.256

9.  Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia.

Authors:  H H Lee; H T Chao; H T Ng; K B Choo
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

Review 10.  Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach.

Authors:  María Arriba; Begoña Ezquieta
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-29       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.